Author

Kate Liu

AstraZeneca (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metabolomics· 1

Frequent Co-Authors

Anton I. RosenbaumiD· 1 shared Ruipeng Mu· 1 shared Taoqing Wang· 1 shared Yue HuangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anton I. RosenbaumORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In-vitro Metabolite Identification for MEDI7219, an Oral GLP-1 Peptide, using LC-MS/MS with CID and EAD Fragmentation

Kate Liu, Yue Huang, Taoqing Wang, Ruipeng Mu, Anton I. Rosenbaum

This study identifies 13 metabolites of the orally-bioavailable GLP-1 peptide MEDI7219 using in vitro pancreatin assays with CID and EAD fragmentation, revealing cleavage sites and enzyme-specific degradation patterns.

Bioanalysis · Jul 3, 2025Peer-reviewedPharmacology & Toxicology